Parents often notice something before anyone else does. A child may not respond to their name, may play differently, or may reach milestones on a different timeline. A 2021 study in the Journal of Pediatric Nursing took those parent observations seriously and used them to build screening tools for families in Iran.
A note on sources: we could only access the study’s abstract, not the full paper. Everything below comes from that abstract, so some details, such as the exact tool items, the specificity of the tools and the authors’ own discussion of limits, are not covered here.
What the study looked at
Most autism screening tools were developed in affluent, English-speaking countries. That raises a fair question: do they capture the early signs that families in other cultures and languages notice?
According to the abstract, the researchers interviewed parents of 623 children aged 3 to 7 years who were considered at risk of autism spectrum disorder (ASD). Parents were asked which signs first raised their concerns.
The researchers also developed and tested two screening instruments with parents. Both used items derived from the Gilliam Autism Rating Scale (GARS-2):
- One focused on autistic behaviors.
- One focused on developmental indicators.
What they found
According to the abstract, when the two tools were used together, they identified 93% of the children who were considered likely to have ASD based on a full GARS assessment.
It helps to be precise about what that number means. The comparison point was a full GARS assessment, which is a rating scale. The abstract does not describe it as a full clinical diagnostic evaluation. The abstract also does not report how often the tools flagged children who did not have ASD, so we cannot say how accurate they are overall.
The authors suggest the tools could be used for initial screening by early-years staff or public health professionals working with Iranian parents who are worried about their child’s development.
What this means for families
This study is not a tool you can use at home, and it was designed for a specific population. Still, a few ideas are useful for any family:
- Your observations matter. The study started from what parents noticed. Details about how your child communicates, plays and interacts are valuable information for professionals.
- Screening is a first step, not a diagnosis. A screening result, positive or negative, is a reason to talk further, not a label.
- Culture and language shape how signs are noticed and described. Tools that fit a family’s context may help more children get seen.
- Writing things down helps. Notes or short videos of what you see can make a conversation with your child’s pediatrician more productive.
If you have concerns about your child’s development, talk with your child’s pediatrician. They can recommend validated screening and, if needed, a referral for a full evaluation. Families do not need to wait for certainty before asking questions.
Limitations to keep in mind
- We only reviewed the abstract, so we cannot report the authors’ full discussion of limitations.
- The children were already considered at risk of ASD. A tool can perform differently in a general population of children, where most do not have ASD.
- The abstract reports the share of likely-ASD children identified (93%), but not how well the tools ruled out children without ASD.
- The reference standard was the GARS, so the result shows agreement with that scale rather than with a full diagnostic evaluation.
- The results come from Iranian families. They should not be assumed to apply to families in Maryland or elsewhere without further study.
How Lucentra Care can help
Lucentra Care provides in-home ABA therapy for young children with autism in Howard, Montgomery, Baltimore, Anne Arundel and Prince George’s counties. If you have questions about next steps after an evaluation, you can contact our team, learn about in-home ABA therapy, or review our insurance coverage guide.
Reference
“Developmental Signs of Autism Spectrum Disorder in Iranian Pre-Schoolers.” Journal of Pediatric Nursing, 2021. PubMed: https://pubmed.ncbi.nlm.nih.gov/33536153/ (author list and DOI not available to us when this article was written; see the PubMed page).
This article summarizes published research for general education and is not medical advice.






